lupus nephritisMoroccan populationLupus nephritis (LN) is a disease with a poor prognosis. The association between LN and the Human leukocyte antigen (HLA) genes has never been studied on a Moroccan population. The aim of this work was to evaluate the distribution of the HLA class II alleles ...
Membranous lupus nephritis (MLN), class V, is a distinct LN characterized by immune complex deposition on subepithelial kidney biopsy. MLN is often associated with nephrotic syndrome. The histology of MLN is very similar to idiopathic (primary) membranous nephropathy (pMN). However, MLN usually has...
Successful Treatment of Class V+IV Lupus Nephritis with Multi-Target Immunosuppressive Therapy. Journal of the American Society of Nephrology : JASNSuccessful treatment of class V IV lupus nephritis with multitarget therapy. H Bao,ZH Liu,HL Xie,WX... H Bao,HL Xie,HT Zhang,... 被引量: 51...
Nephritis in systemic lupus erythematosus is one of the manifestations of organ damage in this autoimmune disease. Class IV is the most ominous among the classes of nephritides and there are conflicting reports on whether class IV-G lupus nephritis differs from class IV-S as defined by the Int...
[1] KEZAR LIFE SCIENCES ANNOUNCES POSITIVE TOPLINE RESULTS FROM THE MISSION PHASE 2 TRIAL EVALUATING ZETOMIPZOMIB FOR THE TREATMENT OF PATIENTS WITH LUPUS NEPHRITIS. Retrieved June 28, 2022 from https://ir.kezarlifesciences.com/news-releases/news-release-details/kezar-life-sciences-announces-positi...
[15] Atara Biotherapeutics Announces Submission of Investigational New Drug Application for ATA3219 for Treatment of Lupus Nephritis. Retrieved February 18, 2024, from https://www.businesswire.com/news/home/20240214963142/en [16] Replicate Bioscience Announces Positive Initial Clinical Results for its ...
3) Pure class V lupus nephritis 单纯性V型狼疮性肾炎 例句>> 4) Membranous lupus nephritis 膜型狼疮肾炎 1. Objective:To investigate the clinical and pathological features of Membranous lupus nephritis(MLN). 目的:总结15例膜型狼疮肾炎(MLN)患者的临床及病理特征。5) Model of Lupus Nephritis ...
[1] KEZAR LIFE SCIENCES ANNOUNCES POSITIVE TOPLINE RESULTS FROM THE MISSION PHASE 2 TRIAL EVALUATING ZETOMIPZOMIB FOR THE TREATMENT OF PATIENTS WITH LUPUS NEPHRITIS. Retrieved June 28, 2022 from https://ir.kezarlifescience...
Control of multiple autoantibodies linked with a lupus nephritis susceptibility locus in New Zealand black mice. An NZB locus on distal chromosome 1 has been linked to murine lupus nephritis in backcross analyses of New Zealand mice. This locus, designated Nba2 for New Zealand Black autoimmunity 2...
Purpose To study the use in real life clinical practise of glucocorticoids (GCs), immunosuppressive and adjuvant therapy in Class III-IV Lupus Nephritis (LN). Methods A multiple choice electronic questionnaire was sent to Latin American rheumatologists. Ten questions addressing the following topics: ...